Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage.
about
Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic aminesFactors and Trends Affecting the Identification of a Reliable Biomarker for Diesel Exhaust ExposureCreating context for the use of DNA adduct data in cancer risk assessment: I. Data organization.Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry.Formalin-fixed paraffin-embedded tissue as a source for quantitation of carcinogen DNA adducts: aristolochic acid as a prototype carcinogenRisk for lung cancer in workers exposed to benzidine and/or beta-naphthylamine: a protocol for systematic review and meta-analysis.An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride.New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.Oxidative stress and HPV carcinogenesis.Multiclass Carcinogenic DNA Adduct Quantification in Formalin-Fixed Paraffin-Embedded Tissues by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry.The use of an artificial nucleotide for polymerase-based recognition of carcinogenic O6-alkylguanine DNA adducts.Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.New and emerging technologies for genetic toxicity testing.The application of mass spectrometry in molecular dosimetry: ethylene oxide as an example.Drug-induced oxidative stress and toxicity.Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study.Mass spectrometry analysis of nucleosides and nucleotides.Determination of site selectivity of different carcinogens for preferential mutational hot spots in oligonucleotide fragments by ion-pair reversed-phase nano liquid chromatography tandem mass spectrometry.Polycyclic aromatic hydrocarbons and PAH-related DNA adducts.Genetic sensor for strong methylating compounds.Interrogation of nucleotide excision repair capacity: impact on platinum-based cancer therapy.Increased risk of lung cancer associated with occupational exposure to benzidine and/or beta-naphthylamine.Mass Spectrometric Characterization of an Acid-Labile Adduct Formed with 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and Albumin in Humans.Using the comet assay and lysis conditions to characterize DNA lesions from the acrylamide metabolite glycidamide.Quantitative analysis of malondialdehyde-guanine adducts in genomic DNA samples by liquid chromatography/tandem mass spectrometry.O⁶-carboxymethylguanine DNA adduct formation and lipid peroxidation upon in vitro gastrointestinal digestion of haem-rich meat.Evaluation of DNA Adducts Formed by Lipid Peroxidation by-Products
P2860
Q28391158-F2088502-C2BA-4181-8A48-9D838AA48884Q28655024-15794BA3-2865-4FA4-9D77-46932F4B88E7Q33501831-7B405046-0762-4770-AA43-FEBB53CCB9BFQ34043981-8BDB95B9-E830-4752-AB87-D4447ADD4668Q34096814-88D3C5F9-BB6A-4257-8AEE-48C3C54FD5D0Q34293437-50D802C2-356F-4128-8C1E-E1E4110D5AACQ35086803-1AD2AFAC-5AEB-42EA-BBAF-F708F71DBD81Q36041371-D32BF06E-3236-48FD-BDD9-D3D387408AE1Q36807150-1C3F64CA-D443-4DF7-B0A6-AA36559CBB05Q36863315-FB99DA42-8B51-402E-93B3-B0F6D212671AQ37211027-78AD7E4F-1142-47A3-9A56-44A1A8416631Q37523243-C6F6A79E-9E32-4419-A358-36ABAC7BAA76Q37782591-B17B93E8-ABE0-40DF-AA96-675680589531Q37844013-FF2428C9-567A-48F5-8985-5805F3B01FC7Q38037517-28065CAD-0C7F-4776-9B5C-D960055EA0F9Q38163594-9C0AE719-EEEA-49CB-BAEE-C8E19497E6B1Q38166984-68784FDE-5AB3-4B04-AD0B-406789F98779Q38306723-2064145A-26E9-4056-97B5-E117CC3CEB76Q39036184-30390B24-D4D8-41E6-A379-44B6C57BE3C5Q41821258-5992669D-B851-476D-B5AA-12ECCDF91AB6Q42566962-17C364F7-0020-4B16-97D2-5E5D3A36874CQ46214668-B881092A-97C9-4471-8538-2FA688EF24BBQ46432390-531749F6-10CC-4BB0-B414-948B5D452613Q47309915-DAF883F3-3EF7-429C-B18D-414B63C396BFQ48201676-86D693BE-7433-43C0-8333-D59095D5D96DQ49060383-AC2F7B68-273C-4196-9837-B03EB9F8D5E9Q57236610-5ED3C5FB-8098-4FAF-BF90-5C69DF5D3BAD
P2860
Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Creating context for the use o ...... nd quantitation of DNA damage.
@ast
Creating context for the use o ...... nd quantitation of DNA damage.
@en
type
label
Creating context for the use o ...... nd quantitation of DNA damage.
@ast
Creating context for the use o ...... nd quantitation of DNA damage.
@en
prefLabel
Creating context for the use o ...... nd quantitation of DNA damage.
@ast
Creating context for the use o ...... nd quantitation of DNA damage.
@en
P2093
P2860
P1476
Creating context for the use o ...... and quantitation of DNA damage
@en
P2093
David E G Shuker
Elizabeth A Martin
James H Kim
Matthew W Himmelstein
Peter B Farmer
Rudranath Persaud
P2860
P304
P356
10.1080/10408440903164163
P407
P577
2009-01-01T00:00:00Z